A predictive model using PSA, quantified ctDNA levels, and ctDNA-detected GADD45 methylation in 34 prostate cancer and 48 healthy subjects yielded a specificity of 87.5%, a sensitivity of 94.1%, and a ROC of 0.937 [41]. This evidence concerns the gene KLK3 and prostate cancer.